DNTH icon

Dianthus Therapeutics

51 hedge funds and large institutions have $162M invested in Dianthus Therapeutics in 2018 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
+3
Holders Change %
+6.25%
% of All Funds
1.17%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
19
Increased
12
Reduced
5
Closed
16
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Millennium Management
51
Millennium Management
New York
-$1.51M -6,984 Closed
Citadel Advisors
52
Citadel Advisors
Florida
-$1.17M -5,425 Closed
Goldman Sachs
53
Goldman Sachs
New York
-$1.02M -4,719 Closed
Alkeon Capital Management
54
Alkeon Capital Management
New York
-$918K -4,250 Closed
UOC
55
UBS O'Connor
Illinois
-$810K -3,750 Closed
DIM
56
DC Investments Management
Virginia
-$558K -2,583 Closed
HI
57
HBK Investments
Texas
-$338K -1,563 Closed
Blackstone Inc
58
Blackstone Inc
New York
-$236K -1,094 Closed
CIBC Private Wealth Group
59
CIBC Private Wealth Group
Georgia
-$215K -994 Closed
Tudor Investment Corp
60
Tudor Investment Corp
Connecticut
-$135K -625 Closed
MWNA
61
Marshall Wace North America
New York
-$135K -625 Closed
SSA
62
Schonfeld Strategic Advisors
New York
-$135K -625 Closed
PHK
63
Point72 Hong Kong
Hong Kong
-$109K -506 Closed
Point72 Asset Management
64
Point72 Asset Management
Connecticut
-$109K -506 Closed
CSS
65
Cubist Systematic Strategies
Connecticut
-$10K -47 Closed
CCA
66
Catalyst Capital Advisors
New York
-$5K -24 Closed
MIM
67
Monashee Investment Management
Massachusetts
-$1.86M